糖尿病患者肾移植的安全性和有效性评估

Safety and effectiveness of kidney transplantation in diabetes mellitus patients

  • 摘要: 目的 评估糖尿病患者肾移植的安全性和有效性。 方法 回顾性分析我中心2008-2012年1 061例肾移植患者的临床资料,根据术前是否患有糖尿病分为糖尿病组(n=116)和非糖尿病组(n=945),分析比较在急性排斥反应(acute rejection,AR)、术后感染、人/肾存活率、不良事件发生情况等方面的差异。 结果 糖尿病组和非糖尿病组AR发生率分别是20.6%和18.3%,差异无统计学意义(P=0.53);糖尿病组和非糖尿病组术后感染率分别是23.3%和15.6%,差异有统计学意义(P=0.03);两组术后1、2、3年人/肾存活率差异无统计学意义(P> 0.05);糖尿病组和非糖尿病组术后不良事件发生率分别是42.2%和32.3%,差异有统计学意义(P=0.03)。 结论 糖尿病患者术后感染率、不良事件发生率均高于普通患者,但并不影响术后人/肾存活率和急性排斥反应发生率;糖尿病可能会降低肾移植术的安全性,但不影响肾移植术的疗效,糖尿病患者可以在保证安全性的前提下进行肾移植术。

     

    Abstract: Objective To assess the safety and effectiveness of kidney transplantation in diabetes mellitus (DM) patients. Methods Clinical data about 1 061 DM patients who underwent kidney transplantation in our center from 2008 to 2012 were retrospectively analyzed. The patients were divided into DM group (n=116) and non-DM group (n=945). The incidence of acute rejection (AR), postoperative infection, adverse events, and the survival rate of patients/kidney were comparatively analyzed. Results No significant difference was found in the incidence of AR between DM group and non-DM group (20.6% vs 18.3%, P=0.53). The incidence of postoperative infection and adverse events was significantly higher in DM group than in non-DM group (23.3% vs 15.6%, P=0.03; 42.2% vs 32.3%, P=0.03). No significant difference was found in the 1-, 2-, and 3- year survival rates of patients and kidney between the two groups after operation (P> 0.05). Conclusion The incidence of postoperative infection and adverse events is higher in DM patients than in ohter patients,but does not affect the survival rate of patients/kidney and the incidence of AR. DM may reduce the safety but not affect the curative effect of kidney transplantation. DM patients can undergo kidney transplantation on the premise of its safety.

     

/

返回文章
返回